An investigation was announced for long term investors in Enochian Biosciences, Inc. (NASDAQ:ENOB) shares over possible breaches of fiduciary duty by certain directors.

San Diego, CA -- (SBWire) -- 11/09/2022 --Certain directors of Enochian Biosciences, Inc. are under investigation over possible breaches of fiduciary duties.

Investors who are current long term investors in Enochian Biosciences, Inc. (NASDAQ: ENOB) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for investors in NASDAQ: ENOB stocks follows a lawsuit filed against Enochian Biosciences, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: ENOB stocks, concerns whether certain Enochian Biosciences, Inc. officers and directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that between September 24, 2020 and May 31, 2022, the Defendants made false and/or misleading statements and/or failed to disclose thatGumrukcu was not a licensed doctor and had no verifiable degrees beyond high school, that accordingly, the scientific and technological underpinnings of Enochian's product pipeline, purportedly invented by Gumrukcu, were dubious at best, that accordingly, the Defendants had significantly overstated the commercial prospects for the Company's product pipeline, that Enochian's senior leadership knew Gumrukcu had a criminal history that included fraud, that accordingly, Enochian's reliance on Gumrukcu, and its consulting and licensing agreements with G-Tech and SRI, subjected the Company to a heightened risk of reputational and financial harm, as well as threatened the integrity of the Company's scientific findings, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Enochian Biosciences, Inc. (NASDAQ: ENOB) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.